Alimera Sciences, Inc. (ALIM) financial statements (2020 and earlier)

Company profile

Business Address 6120 WINDWARD PARKWAY
ALPHARETTA, GA 30005
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8132431317713
Cash and cash equivalents8132431317713
Restricted cash and investments00000  
Receivables161711141011
Inventory, net of allowances, customer advances and progress billings2220222
Inventory2220222
Deferred costs     10
Prepaid expense and other current assets3
Other undisclosed current assets222233 
Total current assets:28353947458319
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment1112321
Intangible assets, net (including goodwill)151719212324
Intangible assets, net (excluding goodwill)151719212324 
Deferred income tax assets1
Deferred tax assets, net   000
Other undisclosed noncurrent assets 110 (0)(0)
Total noncurrent assets:1919212325261
TOTAL ASSETS:475460707010920
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities111099863
Accounts payable7665452
Accrued liabilities4444411
Taxes payable      0
Interest and dividends payable     0 
Debt40003212
Derivative instruments and hedges, liabilities   0 1616
Deferred tax liabilities    00
Other undisclosed current liabilities    0(13)(16)
Total current liabilities:141010940105
Noncurrent Liabilities
Long-term debt and lease obligation35035331333
Long-term debt, excluding current maturities35 3433 333
Finance lease, liability0
Capital lease obligations000100
Liabilities, other than long-term debt4312100
Other liabilities4312100
Total noncurrent liabilities:39335361333
Total liabilities:5314454541448
Stockholders' equity
Stockholders' equity attributable to parent, including:(6)315262650(5)
Common stock11  000
Additional paid in capital348346342331299293240
Accumulated other comprehensive loss(1)(1)(1)(1)(1)(1)(0)
Accumulated deficit(388)(377)(399)(377)(344)(313)(277)
Warrants and rights outstanding44     
Other undisclosed stockholders' equity attributable to parent30307373727032
Total stockholders' equity:(6)315262650(5)
Other undisclosed liabilities and equity 38  31616
TOTAL LIABILITIES AND EQUITY:475460707010920

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues524736342282
Cost of revenue
(Cost of Goods and Services Sold)
(3) (3)(2)(2)(1)(2)
Other undisclosed gross profit(3)(5)    0
Gross profit:464232322170
Operating expenses(53)(52)(49)(60)(60)(40)(34)
Operating loss:(7)(10)(16)(28)(39)(33)(34)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
(0)(0)0(0)(0)(1) 
Interest and debt expense(5)(7)(6)(8)(5)(3)(1)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  03130(11)
Loss from continuing operations before equity method investments, income taxes:(12)(16)(22)(33)(31)(36)(46)
Other undisclosed loss from continuing operations before income taxes     (0) 
Loss from continuing operations before income taxes:(12)(16)(22)(33)(31)(36)(46)
Income tax expense(0)(0)(0)(0)(0)(0) 
Net loss attributable to parent:(12)(16)(22)(33)(31)(36)(46)
Preferred stock dividends and other adjustments 38     
Undistributed earnings (loss) allocated to participating securities, basic44 
Other undisclosed net loss available to common stockholders, basic(4)(4)   (1)(5)
Net income (loss) available to common stockholders, diluted:(12)22(22)(33)(31)(37)(51)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(12)(16)(22)(33)(31)(36)(46)
Other comprehensive income (loss) (0)0(0)(0)(0)(0)
Other undisclosed comprehensive loss(0)      
Comprehensive loss:(12)(17)(22)(33)(31)(36)(47)
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)      
Comprehensive loss, net of tax, attributable to parent:(12)(17)(22)(33)(31)(36)(47)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: